Sri Lankan AI Medical Device "JENDO" Piloted in Bahrain 📈

The Embassy of Sri Lanka in Bahrain, in collaboration with the ICTA, has successfully facilitated the pilot testing of a home-grown cardiovascular screening device at the King Hamad American Mission Hospital. • Innovation: The device, trademarked as JENDO, uses Artificial Intelligence for the non-invasive early detection of cardiovascular conditions and vascular abnormalities through physiological signal analysis. • Pilot Details: Conducted from February 23–25, 2026, the trial focused on clinical integration and usability within Bahrain’s largest American Mission Hospital branch. • Economic Context: Developed by a team led by Keerthi Kodithuwakku, the project highlights the expansion of Sri Lanka's ICT/BPM and digital health sectors into international markets. • Recognition: The technology previously won the Presidential Gold Award in 2025, signaling a shift toward high-value, scalable medical exports for the Sri Lankan economy. • Strategic Impact: This collaboration underscores Sri Lanka's growing capacity for medical innovation and its efforts to commercialize indigenous technology globally.